NHLBI IN THE PRESS

NHLBI-funded researchers identify potential new target for treating diabetes, heart disease

An NHLBI-funded study has identified a potential new target for treating type 2 diabetes and heart disease. In studies using obese mice, researchers showed that a liver enzyme called DPP4 appears to trigger inflammation in abdominal fat and increase insulin resistance. Blocking the liver enzyme could lessen inflammation and insulin resistance, researchers say. The study appeared in Nature.

Media Coverage

|
Medical Xpress
  • Belly fat promotes diabetes under orders from liver
    • |
    Daily Mail
  • Why being apple-shaped increases your risk of diabetes: Study uncovers mysterious link between waistline and insulin resistance
    • |
    Infosurhoy
  • Blitzing belly fat lowers your risk of diabetes and heart issues
    • |
    Science Daily
  • Belly fat promotes diabetes under orders from liver
    • |
    Columbia University Irving Medical Center
  • Belly Fat Promotes Diabetes Under Orders from Liver
    • |
    ScienceNewsline
  • Belly Fat Promotes Diabetes Under Orders from Liver